Internal Medicine Residency

References

• GorenoiV, SchönermarkMP, Hagen A. CT coronary angiography vs. invasive coronary angiography in CHD. GMS Health Technol Assess. 2012;8:Doc02. doi: 10.3205/hta000100. Epub2012 Apr 16. PMID: 22536300; PMCID: PMC3334923
• Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O’Connor RE, Ross MA, Shaw LJ. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 78(22):e187-e285.
• Michos E, Choi A, et al. Coronary Artery Disease in Young Adults.J Am CollCardiol.2019Oct, 74 (15) 1879–1882.https://doi.org/10.1016/j.jacc.2019.08.1023
• VikulovaN, Diana, et. Al. Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex-Related Differences 2000-2016.J of the American Heart Association.Jul 16;8(14):e012178
• Up to date

References

• UpToDate
• Modification of the 2006 Japanese Ministry of Health and Welfare Criteria for the diagnosis of cardiac sarcoidosis Table 1 of 
  Ahmadian A, Brogan A, Berman J, et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis. J Nucl Cardiol. 2014;21(5):925-939. doi:10.1007/s12350-014-9901-9
• MKSAP 19
• Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther. 2016;6(1):50-63. doi:10.3978/j.issn.2223-3652.2015.12.13
• Birnie DH, Nery PB, Ha AC, Beanlands RS. Cardiac Sarcoidosis. J Am Coll Cardiol. 2016;68(4):411-421. doi:10.1016/j.jacc.2016.03.605
• Differential diagnosis and clinical management of diastolic heart failure: current best practice
• https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247680/#E4

References

• Yehuda Adler, Philippe Charron, Massimo Imazio, et.al ESC Scientific Document Group, 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal, Volume 36, Issue 42, 7 November 2015, Pages 2921–2964, https://doi.org/10.1093/eurheartj/ehv318 PMID: 16567581 Originally published March 28,2006 
• Sagristà-Sauleda J, Mercé J, Permanyer-Miralda G, Soler-Soler J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000 Aug 1;109(2):95-101. doi: 10.1016/s0002-9343(00)00459-9. PMID: 10967149.
• Corey GR, Campbell PT, Van Trigt P, Kenney RT, O'Connor CM, Sheikh KH, Kisslo JA, Wall TC. Etiology of large pericardial effusions. Am J Med. 1993 Aug;95(2):209-13. doi: 10.1016/0002-9343(93)90262-n. PMID: 8356985.
• Ma W, Liu J, Zeng Y, Chen S, Zheng Y, Ye S, Lan L, Liu Q, Weig HJ, Liu Q. Causes of moderate to large pericardial effusion requiring pericardiocentesis in 140 Han Chinese patients. Herz. 2012 Mar;37(2):183-7. doi: 10.1007/s00059-011-3428-5. Epub 2011 Feb 9. PMID: 21301790.

References

• Ishida M, Toda K, Nakamura T, et al. Reinforced mitral valve replacement using a xeno pericardium collared prosthetic valve for a heavily calcified or disrupted mitral annulus: a simple "Dumpling technique". Surg Today 2017;47:895–8.
• Sugiyama K, Watanuki H, et al. Prosthetic valve endocarditis caused by silent infection of methicillin-resistant coagulase-negative staphylococci. BMJ case report 2021.
• Galar A, Siedner M, et al. Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management. ASM Journals/Vol 32, No.2.
• Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. 2011. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur Heart J 32:2016–2026.
• Mahesh B, Angelini G, Caputo M, Jin XY, Bryan A. 2005. Prosthetic valve endocarditis. Ann Thorac Surg 80:1151–1158.
• Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG, Jr. 2016. Infective endocarditis. Nat Rev Dis Primers 2:16059.
• UpToDate
• MKSAP 19

References

• Chahoud J, Sharif Yakan A, Saad H, Kanj SS. Right-Sided Infective Endocarditis and Pulmonary Infiltrates: An Update. Cardiol Rev. 2016 Sep-Oct;24(5):230-7. doi: 10.1097/CRD.0000000000000095. PMID: 2650199
• Pericàs JM, Corredoira J, Moreno A, García-País MJ, Falces C, Rabuñal R, Mestres CA, Alonso MP, Marco F, Quintana E, Almela M, Paré JC, Llopis J, Castells A, Miró JM; Hospital Clínic and Hospital Lucus Augusti Infective Endocarditis Investigators. Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients. Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):451-458. English, Spanish. doi: 10.1016/j.rec.2016.10.013. Epub 2017 Mar 9. PMID: 27916708.
• Association. Circulation. 2015 Oct 13;132(15):1435-86. doi: 10.1161/CIR.0000000000000296. Epub 2015 Sep 15. Erratum in: Circulation. 2015 Oct 27;132(17):e215. Erratum in: Circulation. 2016 Aug 23;134(8):e113. Erratum in: Circulation. 2018 Jul 31;138(5):e78-e79. PMID: 26373316.
• Mathew J, Addai T, Anand A, Morrobel A, Maheshwari P, Freels S. Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med. 1995 Aug 7-21;155(15):1641-8. PMID: 7618988.

References

Washington Manual of Medical Therapeutics : 36th edition
https://blackbook.ucalgary.ca/
MKSAP 19

UpToDate - “Periprocedural complications of percutaneous coronary intervention”
UpToDate - “Management of coronary artery perforation during PCI”
NCBI Bookshelf - “TIMI Grade Flow” by Abdullah Sarkar; William S. Grigg; John J. Lee. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482412/
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA). ClinicalTrials.gov ID NCT01471522, Sponsor: NYU Langone Health. Last update posted June 1, 2023. Available at: ClinicalTrials.gov
Ortega-Paz, L., Brugaletta, S., Ariotti, S., Akkerhuis, K. M., Karagiannis, A., Windecker, S., Valgimigli, M., & Steg, P. G. (2018). Adenosine and ticagrelor plasma levels in patients with and without ticagrelor-related dyspnea. Journal of the American Heart Association, 7(12), e008045. https://doi.org/10.1161/JAHA.117.008045